S3 Investment Company

S3 Investment Company is a publicly traded entity (OTC: SIII) that has strategically pivoted into the longevity and biotechnology sectors. The company's core operations are centered on its subsidiary, Humand, which provides a comprehensive platform for human performance optimization and healthspan extension. By integrating advanced diagnostics with AI-driven data analysis, the company offers personalized health protocols designed to monitor and mitigate the biological aging process. S3 Investment Company aims to bridge the gap between complex geroscience research and consumer-accessible longevity solutions. The firm is currently focused on scaling its digital health offerings and integrating innovative biotechnological assets to enhance human longevity.